Table 5.

Infectious complications and antibiotic therapy.

Patients with a novel infection *, n (%)	15 (62%)
Primary source of infection	Lung (n = 11); Urinary tract (n = 1); Mixed lung + urinary tract (2); Mixed lung + primary bacteremia (1)
Type of microorganisms	H. influenzae (2), S. pneumoniae (2), A. baumanii (1), C.koseri (1), S. aureus (1), E. cloacae (2), E. coli (3), K. pneumoniae (1), S. mitis (1); Unspecified enterobacterium (1); C.albicans (1); No documentation (4)
Antibiotic therapy (days), mean ± SD	8.5 ± 4.3
First antibiotics (day after admission)	3.4 ± 1.9

In addition to the 15 patients with a novel infectious complication during their stay, 2 additional patients were receiving antibiotics at inclusion into the study (1 pt with a chronic osteomyelitis, 1 pt with a suspected endocarditis). These 2 patients were not included in the calculation of the duration of antibiotic therapy.